Join the 'Dexedrine' group to help and get support from people like you. How it works
Dexedrine Blog
| Tweet |
Another Drug 'Take-Back Day' Scheduled for Saturday
Posted 26 Apr 2012 by Drugs.com

THURSDAY, April 26 – The fourth National Prescription Drug Take-Back Day is scheduled for Saturday from 10 a.m. to 2 p.m., the U.S. Drug Enforcement Administration says. The event gives Americans an opportunity to safely dispose of unwanted and unused prescription drugs. At the third Take-Back Day last October, participants turned in more than 377,000 pounds (188.5 tons) of unwanted or expired medications at more than 5,300 sites located in all 50 states. In total, the three Take-Back Days have taken in nearly 1 million pounds of prescription drugs during the past 13 months. "The amount of prescription drugs turned in by the American public during the past three Take-Back Day events speaks volumes about the need to develop a convenient way to rid homes of unwanted or expired prescription drugs," DEA administrator Michele Leonhart said in an agency news release. "The DEA remains hard at ... Read more
Related support groups: Suboxone, Xanax, Methadone, Oxycodone, Percocet, OxyContin, Hydrocodone, Vicodin, Adderall, Morphine, Norco, Fentanyl, Klonopin, Lortab, Subutex
Little Evidence of Heart Risks From ADHD Meds
Posted 1 Nov 2011 by Drugs.com

TUESDAY, Nov. 1 – Medications commonly used to treat attention-deficit/hyperactivity disorder don't appear to raise the risk of heart attacks and other cardiovascular problems in children and young adults, new research shows. And if any increased risk from stimulants such as Ritalin, Adderall and Concerta does exist, the danger in absolute numbers would be extremely low, said Dr. William O. Cooper, lead author of a study published online Nov. 1 in the New England Journal of Medicine. "This is the largest study to date, and I feel this provides reassuring information about risk," said Cooper, a professor of pediatrics and preventive medicine at Vanderbilt University in Nashville, Tenn. Almost 3 million children in the United States take prescription medications for attention-deficit/hyperactivity disorder (ADHD) each year. Children with the neurobehavioral disorder have excessive levels ... Read more
Related support groups: Attention Deficit Hyperactivity Disorder (ADHD), Adderall, Concerta, Ritalin, Adderall XR, Focalin, Strattera, Dextroamphetamine, Focalin XR, Methylphenidate, Dexedrine, Methylin, Daytrana, Ritalin LA, Metadate CD
Surge in Number of Americans Treated for Prescription Painkiller Abuse
Posted 23 Jun 2011 by Drugs.com

THURSDAY, June 23 – Rehab admissions related to alcohol, opiates (including prescription painkillers) and marijuana increased in the United States between 1999 and 2009, according to a new national report. However, fewer people sought treatment for problems with cocaine and methamphetamine or amphetamines, the researchers noted. One of the most staggering increases over the 10-year study period: opiate admissions, mostly due to use of prescription opioids, which include painkillers such as oxycodone (Oxycontin) or Vicodin (hydrocodone). The findings showed that 96 percent of the nearly 2 million admissions to treatment facilities that occurred in 2009 were related to alcohol (42 percent), opiates (21 percent), marijuana (18 percent), cocaine (9 percent) and methamphetamine/amphetamines (6 percent). The report from the U.S. Substance Abuse and Mental Health Services Administration ... Read more
Related support groups: Pain, Suboxone, Methadone, Oxycodone, Percocet, OxyContin, Hydrocodone, Vicodin, Adderall, Morphine, Norco, Fentanyl, Lortab, Subutex, Codeine
Can Prescription Amphetamine Use Raise Parkinson's Risk?
Posted 21 Feb 2011 by Drugs.com

SUNDAY, Feb. 20 – Taking prescription amphetamines may raise your risk of developing Parkinson's disease later, new research suggests. But, the researchers noted that the study did not prove a cause-and-effect relationship and further investigation is warranted. Study author Stephen K. Van Den Eeden, a senior investigator at the Division of Research at Kaiser Permanente Northern California, in Oakland, said that people who reported using Benzedrine or Dexedrine at some point in their lives showed a 60 percent greater chance of developing the neurological disorder when compared to those who said they had never taken the medications. "We already know that there are certain risks of amphetamine use," Van Den Eeden said. "This is one concern that is unproven, but we need to take into consideration whether the benefits outweigh the known risks, and maybe potential risks." Amphetamines ... Read more
Related support groups: Adderall, Amphetamine, Adderall XR, Parkinson's Disease, Methamphetamine, Dextroamphetamine, Dexedrine, Desoxyn, Amphetamine/Dextroamphetamine, Dextrostat, Desoxyn Gradumet, ProCentra, Liquadd
Prescriptions for Stimulants, Painkillers Soaring Among Youth
Posted 30 Nov 2010 by Drugs.com

TUESDAY, Nov. 30 – The number of prescriptions for controlled medications such as opioids and stimulants has nearly doubled in adolescents and young adults since 1994. The trend, reported in the December issue of Pediatrics, mirrors a similar increase in misuse of these drugs, with adolescents and young adults' illicit use of prescription drugs now outstripping all other illicit drug use except marijuana. The researchers couldn't attribute the increased misuse directly to more prescriptions, but did urge both physicians and patients to be vigilant when considering the use of drugs such as Oxycontin or Ritalin. "Our study did not look at the relationship between prescribing and misuse, but the increased prescribing increases the potential availability [of these drugs]," said study author Dr. Robert Fortuna, an assistant professor of internal medicine and pediatrics at the University of ... Read more
Related support groups: Suboxone, Methadone, Oxycodone, Percocet, OxyContin, Hydrocodone, Vicodin, Adderall, Morphine, Norco, Fentanyl, Lortab, Subutex, Opana, Phentermine
FDA Medwatch Alert: Stimulant Medications used in Children with Attention-Deficit/Hyperactivity Disorder - Communication about an Ongoing Safety Review
Posted 15 Jun 2009 by Drugs.com
Products involved include: Focalin, Focalin XR (dexmethylphenidate HCl ); Dexedrine, Dexedrine Spansules, Dextroamphetamine ER, Dextrostat (dextroamphetamine sulfate); Vyvanse (lisdexamfetamine dimesylate); Desoxyn (methamphetamine); Concerta, Daytrana, Metadate CD, Metadate ER, Methylin, Methylin ER, Ritalin, Ritalin-LA, Ritalin-SR (methylphenidate); Adderall, Adderall XR (mixed salts amphetamine); Cylert (pemoline) and generics.FDA notified healthcare professionals that it is providing its perspective on study data published in the American Journal of Psychiatry on the potential risks of stimulant medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in children. This study, funded by the FDA and the National Institute of Mental Health (NIMH), compared the use of stimulant medications in 564 healthy children from across the United States who died suddenly to the ... Read more
Related support groups: Attention Deficit Hyperactivity Disorder (ADHD), Adderall, Vyvanse, Concerta, Focalin, Dexedrine, Desoxyn, Cylert
FDA Medwatch Alert: Dextroamphetamine Sulfate 5mg Tablets
Posted 16 Oct 2008 by Drugs.com
[Posted 10/16/2008] Ethex Corp and FDA notified healthcare professionals of a voluntary recall of three lots of Dextroamphetamine Sulfate 5mg tablets. The product was recalled due to the potential presence of oversized tablets that may contain as much as twice the labeled amount of the active ingredient. Taking a higher than expected dose of Dextroamphetamine Sulfate may be associated with an increased risk of adverse effects such as tachycardia, hypertension, tremors, decreased appetite, headache, insomnia, dizziness, blurred vision, stomach upset, and drug mouth. Consumers and their caregivers should not use any Dextroamphetamine Sulfate tablets that appear to be oversized and should consult their healthcare professional with any questions.[October 15, 2008 - Press Release - Ethex] Read more
Related support groups: Dexedrine
FDA Medwatch Alert: Dexedrine (dextroamphetamine sulfate)
Posted 21 Aug 2006 by Drugs.com
[Posted 08/21/2006] The FDA and GlaxoSmithKline notified healthcare professionals of changes to the BOXED WARNING, WARNINGS and PRECAUTIONS sections of the prescribing information for Dexedrine (dextroamphetamine sulfate), approved for the treatment of Attention-Deficit Hyperactivity Disorder and narcolepsy. The warnings describe reports of sudden death in association with CNS stimulant treatment at usual doses in children and adolescents with structural cardiac abnormalities or other serious heart problems. [August 04, 2006 - Letter - GlaxoSmithKline] [June 2006 - Label - GlaxoSmithKline] Read more
Related support groups: Dexedrine
Ask a Question
Further Information
Related Condition Support Groups
Attention Deficit Hyperactivity Disorder (ADHD), Narcolepsy, Sexual Dysfunction, SSRI Induced
